...
首页> 外文期刊>Pharmacoepidemiology and drug safety >Prescribing potentially inappropriate medication (PIM) in Germany's elderly as indicated by the PRISCUS list. An analysis based on regional claims data.
【24h】

Prescribing potentially inappropriate medication (PIM) in Germany's elderly as indicated by the PRISCUS list. An analysis based on regional claims data.

机译:规定德国老年人的潜在不恰当的药物(PIM),如priscus列表所示。 基于区域声明数据的分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to estimate the prevalence of potentially inappropriate medication (PIM) in the elderly as indicated by Germany's recently published list (PRISCUS) and to assess factors independently associated with PIM prescribing, both overall and separately for therapeutic groups.Claims data analysis (Health Insurance Sample AOK Hesse/KV Hesse, 18.75% random sample of insurants from AOK Hesse, Germany) is used in the study. The study population is composed of 73?665 insurants >64?years of age continuously insured in the last quarter of 2009 and either continuously insured or deceased in 2010. Prevalence estimates are standardized to the population of Germany (31 December 2010). The variables age, sex, polypharmacy, hospital stay and nursing care are assessed for their independent association with general PIM prescription and among 11 therapeutic subgroups using multivariate logistic regression analysis.In 2010, 22.0% of the elderly received at least one PIM prescription (men: 18.3%, women: 24.8%). The highest PIM prevalence was observed for antidepressants (6.5%), antihypertensives (3.8%) and antiarrhythmic drugs (3.5%). Amitriptyline, tetrazepam, doxepin, acetyldigoxin, doxazosin and etoricoxib were the most frequently prescribed PIMs. Multivariate analyses indicate that women (OR 1.39; 95% CI: 1.34-1.44) and persons with extreme polypharmacy (≥10 vs. <5 drugs: OR 5.16; 95% CI: 4.87-5.47) were at higher risk for receiving a PRISCUS-PIM. Risk analysis for therapeutic groups shows divergent associations.PRISCUS-PIMs are widely used. Educational programs should focus on drugs with high treatment prevalence and call professionals' attention to those elderly patients who are at special risk for inappropriate medication. Copyright ? 2013 John Wiley & Sons, Ltd.
机译:本研究的目的是估算老年人潜在的不适当药物(PIM)的普遍性,如德国最近公布的名单(priscus),并评估与PIM规定的因素,整体和分别用于治疗组。根据数据分析(健康保险样本AOK Hesse / KV Hesse,德国Aok Hesse的18.75%的保险人样本)用于该研究。该研究人口由73人组成73. 665岁的保险人员> 64岁时在2009年的上一季度不断投保,2010年不断投保或死者。普遍存在估计是德国人口标准化(2010年12月31日)。评估变量年龄,性别,多酚省,住院住宿和护理,以与一般PIM处方和使用多元逻辑回归分析的11个治疗亚组之间的独立协会评估。2010年,22.0%的老人收到至少一个PIM处方(男性:18.3%,女性:24.8%)。观察到抗抑郁药(6.5%),抗高血压(3.8%)和抗心律失常药物(3.5%)的最高PIM患病率。 Amitriptyline,Tetrazepam,Doxepin,acetyldigoxin,doxazosin和etoricoxib是最常规定的PIM。多变量分析表明,女性(或1.39; 95%CI:1.34-1.44)和极端多药物的人(≥10vs. <5药物:或5.16; 95%CI:4.87-5.47)接受Priscus的风险较高-PIM。治疗组的风险分析显示出不同的关联.PIMS-PIM被广泛使用。教育计划应专注于具有高处理患病率的药物,并呼吁专业人员对那些处于特殊风险的老年患者对不适当的药物影响。版权? 2013年John Wiley&Sons,Ltd。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号